Skip to content

Prophylactic effect of phenylephrine on post-spinal hypotension during cesarean section

Comparison of prophylactic infusion of phenylephrine with ephedrine for prevention of hypotension in elective cesarean section under spinal Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012120911700N1
Enrollment
90
Registered
2013-07-21
Start date
2012-03-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Anesthesia, Hypotention. Other complications of spinal and epidural anaesthesia during the puerperium

Interventions

Intervention 1: Intervention group1: Infusion of 450 micrograms Phenylephrine in 250 milliliters of normal saline during 30 minutes before performing spinal anesthesia. Intervention 2: Intervention gr
Treatment - Drugs
Placebo
Intervention group1: Infusion of 450 micrograms Phenylephrine in 250 milliliters of normal saline during 30 minutes before performing spinal anesthesia
Intervention group 2: Infusion of 45 milligrams Ephedrine in 250 milliliters of normal saline during 30 minutes before performing spinal anesthesia
Control group::Infusion of 250 milliliters of normal saline during 30 minutes before performing spinal anesthesia

Sponsors

Vice chancellor for research, Tabriz University of Medical Sceince
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criterion: any healthy pregnant women with gestational age of 36 weeks or higher and non emergency cesarean section. Exclusion criteria: gestational age less than 36 weeks; emergency cesarean section; any contraindication of spinal anesthesia (patient refusal , coagulopathy , hemorrhage or hypovolemic shock) and unexpected events during surgery such a hemorrhage or sensory block level blow or higher then T4-T5 after spinal anesthesia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: Every 5 minute until fetal delivery,then every 5 minute throughout surgery. Method of measurement: Noninvasive blood pressure control with noninvasive mamometer.;Maternal complications(Dysrhythmias,nausea and vomiting,other complications) ting,other complications. Timepoint: Continuous Inspection. Method of measurement: Electrocardiogram, continuous Inspection.

Secondary

MeasureTime frame
Neonatal outcome. Timepoint: 1st and 5th minutes Apgar Scores after neonatal delivery. Method of measurement: 1st and 5th minutes Apgar Scoring system.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnaz Moslemi Tabrizi

Tabriz University of Medical Sciences

moslemifa@gmail.com+98 41 1329 6295

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026